New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
10:04 EDTFOSL, TRW, DECK, VRNT, LH, UAMOn the Fly: Analyst Initiation Summary
Fossil (FOSL) initiated with a Neutral at Sterne Agee... TRW Automotive (TRW) initiated with a Neutral at UBS... Deckers Outdoor (DECK) initiated with a Buy at B. Riley... Verint Systems (VRNT) reinstated with an Outperform at Credit Suisse... LabCorp (LH) assumed with a Buy at Maxim... Universal American (UAM) initiated with a Market Perform at Leerink.
News For FOSL;TRW;DECK;VRNT;LH;UAM From The Last 14 Days
Check below for free stories on FOSL;TRW;DECK;VRNT;LH;UAM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
10:42 EDTTRWOptions with increasing implied volatility
Subscribe for More Information
August 26, 2014
11:44 EDTTRWOptions with increasing implied volatility
Options with increasing implied volatility: TLM CODE TRW GILD WTW PSEC
11:31 EDTTRWTRW September volatility elevated
Subscribe for More Information
11:31 EDTFOSLMovado tumbles after second quarter results, outlook miss estimates
Shares of luxury watch maker Movado (MOV) are falling after the company's second quarter results and fiscal 2015 outlook missed analysts' consensus estimates. WHAT'S NEW: This morning, Movado reported Q2 adjusted earnings per share of 44c and revenue of $143.6M, missing analysts' consensus estimates of 54c and $152.99M, respectively. Q2 gross profit was 54% of sales, compared to 54.1% of sales, in the prior year period. Gross margin percentage remained relatively flat as a result of the unfavorable impact of changes in foreign currency exchange rates, offset by the leverage gained on certain fixed costs due to increased sales. WHAT'S NOTABLE: Movado forecast FY15 EPS of $2.44, slightly short of the consensus of $2.46. FY15 revenue was seen at $640M, compared to consensus of $640.17M, while FY15 gross margin is expected to be approximately flat, year over year. Efraim Grinberg, Chairman and CEO, stated , "We anticipate our sales growth to accelerate during the second half of the year, as strong sell-through rates at retail are expected to drive new shipments and replenishment growth and we continue to benefit from the expansion of our Movado and licensed brands around the world. We will also continue to invest in our infrastructure and growth initiatives, including investments in Asia and Latin America. We continue to believe that our strategies have us positioned to achieve our goal of delivering sustainable profitable growth." PRICE ACTION: In late morning trading, Movado fell $3.08, or about 7%, to $40.96 on heavy trading volume. Despite today's pull back, the stock is up almost 8% over the past 12 months. OTHERS TO WATCH: Movado's peer, Fossil Group (FOSL), is up 0.2% on the session.
August 25, 2014
14:17 EDTTRWTRW Automotive falls 1.8% to $96.21
Subscribe for More Information
August 19, 2014
11:32 EDTLHLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.
08:47 EDTLHLabCorp announces availability of InformaSeq non-invasive prenatal test
Laboratory Corporation of America Holdings announced the availability of the informaSeq Prenatal Test. The informaSeq Prenatal Test is an advanced, non-invasive, next-generation prenatal screening assay that can assess risk for multiple fetal chromosomal aneuploidies, or abnormalities in the number of chromosomes, from a single maternal blood draw. There are testing options for several additional common sex-related aneuploidies. The test is offered through Integrated Genetics, part of the LabCorp Specialty Testing Group of laboratories that offer advanced esoteric and genomic testing.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use